Mergers & Acquisitions Mergers & Acquisitions

Comment: CVS Health’s vertical deal for Signify Health could raise entry barrier, market power concerns

By Flavia Fortes
  • 08 Sep 2022 20:29
  • 08 Sep 2022 20:29
CVS Health’s $8 billion bid for home care provider Signify Health could attract antitrust scrutiny over entry barriers and the companies’ strengthened position in the healthcare market.

Even though the companies say there are no overlapping businesses between them, antitrust regulators have been wary of market consolidation in general, particularly in healthcare.

Long gone

To view the latest version of this document and thousands of others like it, sign-in to MLex or register for a free trial.

Discover MLex

Stay on top of global regulatory developments


Latest News